Battini, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 536
EU - Europa 353
AS - Asia 141
SA - Sud America 4
AF - Africa 3
OC - Oceania 1
Totale 1.038
Nazione #
US - Stati Uniti d'America 532
IT - Italia 92
SE - Svezia 89
CN - Cina 60
SG - Singapore 48
IE - Irlanda 40
RU - Federazione Russa 26
DE - Germania 25
GB - Regno Unito 19
FR - Francia 18
UA - Ucraina 17
IN - India 13
FI - Finlandia 9
HK - Hong Kong 8
CZ - Repubblica Ceca 7
IR - Iran 5
BR - Brasile 3
CI - Costa d'Avorio 3
KR - Corea 3
PL - Polonia 3
CA - Canada 2
CH - Svizzera 2
PA - Panama 2
RS - Serbia 2
AR - Argentina 1
AU - Australia 1
BE - Belgio 1
DK - Danimarca 1
NL - Olanda 1
NO - Norvegia 1
NP - Nepal 1
TH - Thailandia 1
TR - Turchia 1
VN - Vietnam 1
Totale 1.038
Città #
Chandler 140
Ashburn 54
New York 41
Dublin 39
Singapore 23
Moscow 22
Wilmington 19
Fairfield 18
Rome 16
Dearborn 13
Inverigo 13
Nanjing 13
Princeton 13
San Mateo 13
Boston 12
Houston 11
Lancaster 11
Milan 11
Ann Arbor 8
Hong Kong 8
Munich 7
Bremen 6
Brno 6
Marseille 6
Redwood City 6
Augusta 5
Cinisello Balsamo 5
Jacksonville 5
Busto Arsizio 4
Cattolica 4
Guangzhou 4
Helsinki 4
Nanchang 4
Palermo 4
Abidjan 3
Beijing 3
Chicago 3
Jiaxing 3
Kish 3
Lawrence 3
Leawood 3
Los Angeles 3
San Jose 3
Seoul 3
São Paulo 3
Woodbridge 3
Zhengzhou 3
Belgrade 2
Cambridge 2
Changsha 2
Dallas 2
Hebei 2
Indore 2
Kazan' 2
Menlo Park 2
Mozzate 2
Norwalk 2
Pune 2
San Diego 2
San Francisco 2
Sandston 2
Seattle 2
Teramo 2
Tianjin 2
Warsaw 2
Andover 1
Bangkok 1
Bern 1
Brussels 1
Clearwater 1
Cupertino 1
Dong Ket 1
Fara 1
Frankfurt am Main 1
Haikou 1
Hangzhou 1
Hefei 1
Henderson 1
Hounslow 1
Islington 1
Jinan 1
Kathmandu 1
Kocaeli 1
Kunming 1
Lappeenranta 1
Logan 1
London 1
Mantova 1
Mentana 1
Mountain View 1
Mumbai 1
Naples 1
Nashville 1
Nijmegen 1
Ningbo 1
Oslo 1
Parma 1
Poggio Mirteto 1
Polska 1
Prague 1
Totale 678
Nome #
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 86
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 72
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 67
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 67
6 minute walk test in duchenne MD patients with different mutations:12 month changes 64
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 62
Functional levels and MRI patterns of muscle involvement in upper limbs in Duchenne muscular dystrophy. 62
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 57
Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment? 55
Early neurodevelopmental characterization in children with cobalamin C/defect 50
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy 49
Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review 45
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 44
Patient-reported outcomes measure for children born preterm: validation of the SOLE VLBWI Questionnaire, a new quality of life self-assessment tool 41
A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine 29
Cortical Thickness and Clinical Findings in Prescholar Children With Autism Spectrum Disorder 22
Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome 22
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 21
Challenges and resources in adult life with Joubert syndrome: issues from an international classification of functioning (ICF) perspective 19
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: An Italian comparative study 18
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 16
Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month Study 16
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 13
Longitudinal data of neuropsychological profile in a cohort of Duchenne muscular dystrophy boys without cognitive impairment 12
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 10
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 9
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 8
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 7
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 7
The Hammersmith functional score correlates with the SMN2 copy number: A multicentric study 6
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 5
Daily salbutamol in young patients with SMA type II 4
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 4
"I have got something positive out of this situation": Psychological benefits of caregiving in relatives of young people with muscular dystrophy 3
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study 3
Reliability of the North Star Ambulatory Assessment in a multicentric setting 3
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 3
Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: The role of executive functions 2
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 2
Totale 1.085
Categoria #
all - tutte 8.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202045 0 0 1 1 1 6 16 0 3 1 15 1
2020/202163 1 4 0 6 2 5 10 1 7 10 15 2
2021/2022148 15 5 0 12 9 10 4 28 9 4 26 26
2022/2023378 44 45 21 70 23 48 10 36 48 4 20 9
2023/2024339 11 53 6 12 10 56 67 18 2 11 37 56
2024/202534 18 12 4 0 0 0 0 0 0 0 0 0
Totale 1.085